Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rhabdoid Tumor × Vincristine × Clear all

Phase

Phase 3 3 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 98 Lymphoma, Large B-Cell, Diffuse 70 Precursor Cell Lymphoblastic Leukemia-Lymphoma 58 Leukemia 41 Burkitt Lymphoma 39 Lymphoma, Non-Hodgkin 31 Lymphoma, Mantle-Cell 27 Lymphoma, Follicular 26 Hodgkin Disease 20 Sarcoma 16 Central Nervous System Neoplasms 15 Neuroblastoma 14 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma, B-Cell 11 Lymphoma, Large-Cell, Anaplastic 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, T-Cell, Peripheral 9 Dendritic Cell Sarcoma, Interdigitating 9 Sarcoma, Ewing 8 Neoplasms 8 Lymphoma, B-Cell, Marginal Zone 8 Neuroectodermal Tumors, Primitive, Peripheral 7 Multiple Myeloma 7 Medulloblastoma 7 Rhabdomyosarcoma 6 Retinoblastoma 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Leukemia, Biphenotypic, Acute 6 HIV Infections 6 Wilms Tumor 5

Interventions

Magnetic Resonance Spectroscopy 7 X-Rays 6 Phantoms, Imaging 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Cyclophosphamide 4 Biopsy 4 palbociclib 3 Topotecan 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 olaparib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Vemurafenib 2 LY3023414 2 Etoposide 2 selinexor 1 cabozantinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Temozolomide 1 Stem Cell Transplantation 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡